NOV (NOV)
(Delayed Data from NYSE)
$18.67 USD
+0.42 (2.30%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $18.66 -0.01 (-0.05%) 4:28 PM ET
4-Sell of 5 4
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.67 USD
+0.42 (2.30%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $18.66 -0.01 (-0.05%) 4:28 PM ET
4-Sell of 5 4
A Value F Growth C Momentum C VGM
Zacks News
Nov Inc. (NOV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Analysts Think Nov Inc. (NOV) Could Surge 51.82%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Nov Inc. (NOV) points to a 51.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Do Options Traders Know Something About NOV Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to NOV stock based on the movements in the options market lately.
Why Nov Inc. (NOV) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Nov Inc. (NOV) Down 8.1% Since Last Earnings Report?
by Zacks Equity Research
Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Go Beyond Bargain Hunting, Buy 5 Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include OpGen (OPGN), Horizon Technology Finance (HRZN), Equity Commonwealth (EQC), NOV (NOV) and Spartacus Acquisition (NN).
Nov Inc. (NOV) Loses -14.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Nov Inc. (NOV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
NOV Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
NOV issues a positive outlook for 2023, with a low-double-digit EBITDA margin and a mid-single-digit revenue increase in Completion & Production Solutions segment.
Nov Inc. (NOV) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of 45.45% and 0.37%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
NOV Q1 Earnings Preview: Here's Everything You Need to Know
by Zacks Equity Research
While strong results from Rig Technologies and Wellbore Technologies units are likely to have boosted NOV Inc.'s (NOV) first-quarter results, escalation in costs might have neutralized those gains.
Earnings Preview: Distribution Solutions Group (DSGR) Q1 Earnings Expected to Decline
by Zacks Equity Research
Distribution Solutions (DSGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nov Inc. (NOV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nov Inc. (NOV) Down 2.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
NOV Slides Despite Cruising Past Q4 Earnings: Here's Why
by Zacks Equity Research
At the end of 2022, NOV's capital equipment order backlog for Rig Technologies was $2.79 billion, including $254 million worth of new orders.
Nov Inc. (NOV) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of 13.04% and 6.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Patterson-UTI's (PTEN) Q4 Earnings: Another Beat in the Cards?
by Zacks Equity Research
Higher revenues from the Contract Drilling and Pressure Pumping segments are likely to have boosted Patterson-UTI Energy's (PTEN) fourth-quarter results.
NOV to Report Q4 Earnings: Is the Stage Set for a Beat?
by Zacks Equity Research
Higher revenues from the Rig Technologies and Wellbore Technologies segments are likely to have boosted NOV Inc.'s (NOV) fourth-quarter results.
Jacobs Solutions (J) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Jacobs Solutions (J) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nov Inc. (NOV) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nov Inc. (NOV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nov Inc. (NOV) Soars 5.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Nov Inc. (NOV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Should iShares Morningstar SmallCap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
NOV Inc. (NOV) Earnings Lag, Sales Outperform Estimates in Q3
by Zacks Equity Research
NOV Inc.'s (NOV) third-quarter earnings lag estimates, while revenues beat the consensus mark due to solid segmental performances.
Nov Inc. (NOV) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Nov Inc. (NOV) Misses Q3 Earnings Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of -46.67% and 4.19%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is NOV (NOV) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Nov Inc. (NOV) and Quest Resource (QRHC) have performed compared to their sector so far this year.